tm logo
Trademark Search
ASCENTAGE PHARMA DESIGN
ASCENTAGE PHARMA DESIGN
REGISTERED

on 19 Aug 2021

Last Applicant/ Owned by

JIANGSU ASCENTAGE PHARMA INC.

101 Room of First FloorQB3 Building, Medical City Avenue, TaizhaoJiangsu, 225300

CN

Serial Number

1882949 filed on 13th Feb 2018

Registration Number

TMA1107232 registered on 19th Aug 2021

Registration expiry Date

19th Aug 2031

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ASCENTAGE PHARMA DESIGN

Trademark usage description

medicines for the treatment of cancer, tumors, blood-related diseases, lower respiratory diseases, hiv/aids, diarrheal diseases, tuberculosis, malaria Read More

Classification Information


Class [005]
Medicines for the treatment of cancer, tumors, blood-related diseases, lower respiratory diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; drugs for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of dental and oral diseases; botanicals for the treatment of dental and oral diseases; homeopathic remedies for the treatment of dental oral diseases; antibiotics; pharmaceutical preparations in the form of injection for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals;; active pharmaceutical ingredients for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicinal oils for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical laboratory use; diagnostic preparations for clinical laboratory use; diagnostic biomarker reagents for medical purposes; medicated candy for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; food supplements consisting of amino acids; food supplements consisting of trace elements; vitamin and mineral food supplement; dietetic beverages consisting of vitamins, minerals, amino acids and trace elements; dietetic substances consisting of vitamins, minerals, ani acids and trace elements; mineral food supplements; nutritional supplements for the treatment and relief of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumpsage-related, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease


Classification kind code

11

Mark Details


Serial Number

1882949

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 19th May 2021
Advertised
Submitted for opposition 27
on 23rd Apr 2021
Approval Notice Sent
Submitted for opposition 26
on 23rd Apr 2021
Approved
Submitted for opposition 15
on 23rd Sep 2020
Correspondence Created
Submitted for opposition 15
on 24th Feb 2020
Correspondence Created
Submitted for opposition 22
on 15th May 2019
Search Recorded
Submitted for opposition 20
on 15th May 2019
Examiner's First Report
Submitted for opposition 31
on 16th Feb 2018
Formalized
Submitted for opposition 1
on 14th Feb 2018
Created
Submitted for opposition 30
on 13th Feb 2018
Filed